MannKind Corporation and Tolero Pharmaceuticals Company Profile

News Articles [ 92 Associated News Articles listed on BioPortfolio]

Alliance Deal of the Year Nominee: Tolero/Mannkind

It's time for the IN VIVO Blog's Fifth Annual Deal of the Year! competition. This year we're once again presenting awards in three categories to highlight the most interesting and creative deal making...

Pursuing proof of mechanism: Sidebar: Tolero Pharmaceuticals Inc. Corporate Profile

Tolero: Pursuing proof of mechanism Tolero Pharmaceuticals Inc. Salt Lake City, Utah Technology: N/A Disease focus: Cancer, autoimmune Clinical status: Preclinical Founded: 2011 by Dallin Anderson and...

With Share Offering Registration And Trial Enrollment Complete, Time To Buy MannKind

By Rx Stocks:Mannkind (MNKD) is a speculative buy. Two key pieces of information were needed to at least assure that an NDA would be filed for Afrezza. (1) Mannkind needed money to complete the phase...

MannKind Gets Commitment From Mann Group To Buy 40 Mln Shares & Warrants

WASHINGTON (dpa-AFX) - MannKind Corp. (MNKD) said it has reached a purchase agreement with The Mann Group LLC, an entity controlled by MannKind's chief executive officer and principal stockholder,...

Giant leap for MannKind's Affrezza as Colby takes immunotherapies off back burner

MannKind stands to gain up to $140 million in upfront and milestone payments plus royalties under a license agreement with Colby Pharmaceutical, which will take over development of novel MKC1106 immu...

Tolero Pharmaceuticals announces Worldwide Agreement with Sanofi for the In-license of Alvocidib (Flavopiridol)

SALT LAKE CITY, May 1, 2013 /PRNewswire-iReach/ -- Tolero Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel therapeutics to treat cancer and other se...

[Colby] gets exclusive rights to [MannKind]'s cancer immunotherapy program

[Colby Pharmaceutical Co.] (signal transduction modulators and immune modulators for various diseases) has licensed exclusive worldwide rights to develop and sell diabetes and cancer firm [MannKind Co...

MannKind Corporation to Present at JMP Securities 7th Annual Healthcare Conference

MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the JMP Sec...

Drugs and Medications [0 Results]

None

PubMed Articles [ 5 Associated PubMed Articles listed on BioPortfolio]

Insulin Lung Deposition and Clearance Following Technosphere(®) Insulin Inhalation Powder Administration.

PURPOSE: To determine distribution and deposition of Technosphere(®) Insulin (TI) inhalation powder and the rate of clearance of fumaryl diketopiperazine (FDKP; major component of Technosphere partic...

A new C-peptide correction model used to assess bioavailability of regular human insulin.

The clinical assessment of new formulations of human insulin is problematic due to the inability to distinguish between endogenous insulin and exogenously administered insulin. The usual methods to su...

Multivalent immunity targeting tumor-associated antigens by intra-lymph node DNA-prime, peptide-boost vaccination.

Active immunotherapy of cancer has yet to yield effective therapies in the clinic. To evaluate the translatability of DNA-based vaccines we analyzed the profile of T-cell immunity by plasmid vaccinati...

Insulin pharmacokinetics following dosing with Technosphere insulin in subjects with chronic obstructive pulmonary disease.

Abstract Objectives: Insulin exposure after inhalation has been reported to be altered significantly in subjects with chronic obstructive pulmonary disease (COPD). In this study, the rate and extent o...

Potent and Selective Inhibitors of the Inositol-requiring Enzyme 1 Endoribonuclease.

Inositol-requiring enzyme 1 (IRE1) is the most highly conserved signaling node of the unfolded protein response (UPR) and represents a potential therapeutic target for a number of diseases associated...

Clinical Trials [0 Results]

None

Companies [ 3 Associated Companies listed on BioPortfolio]

MannKind Corporation and Tolero Pharmaceuticals

Tolero is a biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat and cure cancer and other life-threatening diseases. Tolero has use...

MannKind Corporation

MannKind Corporation (Nasdaq:MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its...

MannKind

MannKind is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Our lead investigational product c...